Brazil's National Health Surveillance Agency of Brazil (Anvisa) Wednesday authorized the Butantan Institute to carry out human tests of the locally-produced ButanVac immunizer.
Paraguayan President Mario Abdo Benítez Tuesday reached out to his Brazilian colleague Jair Bolsonaro to negotiate the purchase of medical oxygen above the current quota because it is not enough, according to health authorities.
Brazil's National Health Surveillance Agency (Anvisa) Friday approves, albeit with some restrictions, imports of Covaxin and Sputnik V doses for use in up to 1% of the country's population, it was announced.
The Brazilian Government of President Jair Bolsonaro Monday banned the entry of foreigners “of any nationality” as a result of the number of cases of covid-19 growing faster than expected, it was announced.
Brazil's Health Ministry Tuesday announced that vaccination of pregnant women and mothers in Brazil against Covid-19 will be restricted only to patients with comorbidities (pre-existing diseases) and they would only be given CoronaVac or Pfizer vaccines, following a death which might be linked to the AstraZeneca immunizer.
The Russian manufacturers of the Sputnik V vaccine have filed a libel lawsuit in Brazil against the country's National Health Surveillance Agency (Anvisa) for “intentionally spreading false and inaccurate information” about the covid-19 inoculator after prohibiting its import, citing lack of data, the immunizer's Twitter account (@sputnikvaccine) reported.
Brazil's National Health Surveillance Agency (Anvisa) Monday recommended against the import of the Russian-made Sputnik V vaccine to fight the covid-19 pandemic, citing lack of proper documents required for approval as well as other health risks the antidote may imply.
Brazil's National Health Surveillance Agency (Anvisa) will evaluate this coming week the feasibility of importing the Russian-manufactured Sputnik V vaccine against covid-19.
While Argentina has already started trials to produce the Russian Sputnik V vaccine against covid-19, Brazil’s National Health Surveillance Agency (Anvisa) has filed a petition before the Federal Supreme Court (STF) for additional time to evaluate a registration request for the very same immunization shot.
Brazil's National Health Surveillance Agency (Anvisa) has given the green light to clinical trials on volunteers of a potential anti-Covid-19 vaccine produced by the Chinese laboratory Sichuan Clover Biopharmaceuticals, it was announced.